Answers are grounded in this paper and cite their sources.
New data on the laboratory diagnostics of lipid metabolism disorders are presented based on the latest guidelines of the Russian Society of Cardiology (from 2023) and a joint document published in 2020 by the Joint Consensus Panel of the European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) “Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM” with the aim of improving the laboratory diagnostics of atherogenic dyslipidemias, introducing a modern arsenal of laboratory tests into widespread clinical practice and improving knowledge about modern methods for diagnosing lipid metabolism disorders.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: